Image pharmaphorum Editor Oncology Realising the promise of genomic testing across oncology Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world. Oncology Diversity by design: the importance of DE&I in oncology tria... “First, do no harm”; is an ethical axiom at the heart of medical research; physicians worldwide pledge to uphold the oath to serve patients. Oncology Immunotherapy: building the fourth pillar of cancer treatmen... Cancer treatment has been traditionally characterised by surgery, chemotherapy, and radiation. Views & Analysis Digital tools driving innovative clinical trials The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the cl Load more results
Oncology Realising the promise of genomic testing across oncology Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world.
Oncology Diversity by design: the importance of DE&I in oncology tria... “First, do no harm”; is an ethical axiom at the heart of medical research; physicians worldwide pledge to uphold the oath to serve patients.
Oncology Immunotherapy: building the fourth pillar of cancer treatmen... Cancer treatment has been traditionally characterised by surgery, chemotherapy, and radiation.
Views & Analysis Digital tools driving innovative clinical trials The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the cl
News Pharma leaders urge Europe to halt 'slow agony' of decline Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
